Risk of Hepatitis B Virus Reactivation in Patients Who Are Hepatitis B Surface Antigen Negative/Antibody to Hepatitis B Core Antigen Positive and the Role of Routine Antiviral Prophylaxis-Reference-Cited by-同舟云学术

Risk of Hepatitis B Virus Reactivation in Patients Who Are Hepatitis B Surface Antigen Negative/Antibody to Hepatitis B Core Antigen Positive and the Role of Routine Antiviral Prophylaxis

Published:2009-05-20 Issue:15 Volume:27 Page:2570-2571
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Koo Yu Xuan¹,Tan Daniel S.W.²,Tan Bee Huat²,Quek Richard²,Tao Miriam²,Lim Soon Thye²

Affiliation:

1. Yong Loo Lin School of Medicine, National University of Singapore; Department of Medical Oncology, National Cancer Centre Singapore, Singapore

2. Department of Medical Oncology, National Cancer Centre Singapore, Singapore

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2009.21.9352

Reference5 articles.

1. Hepatitis B Virus Reactivation in Lymphoma Patients With Prior Resolved Hepatitis B Undergoing Anticancer Therapy With or Without Rituximab

2. Risk of Hepatitis B Virus (HBV) Reactivation and Role of Anti-Viral Prophylaxis in Lymphoma Patients with Past HBV Infection (HBV Antigen negative but anti-Hepatitis B core antibody positive) Receiving Chemo-Immunotherapy

3. Hepatitis B virus-related liver disease in isolated anti-hepatitis B-core positive lymphoma patients receiving chemo- or chemo-immune therapy

4. Lamivudine for the Prevention of Hepatitis B Virus Reactivation in Hepatitis B s-Antigen Seropositive Cancer Patients Undergoing Cytotoxic Chemotherapy

5. Prophylaxis and treatment of hepatitis B in immunocompromised patients

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging Therapeutic Options for Refractory Pulmonary Sarcoidosis: The Evidence and Proposed Mechanisms of Action;Journal of Clinical Medicine;2023-12-19

2. Hepatitis B immunoglobulin (HBIG) combined with long-term entecavir prophylaxis for hepatitis B virus infection in allogeneic hematopoietic stem cell transplantation with hepatitis B surface antigen-positive donors;Leukemia & Lymphoma;2021-03-18

3. B cell dysfunction in chronic hepatitis B virus infection;Liver Research;2021-03

4. Entecavir prophylaxis for hepatitis B virus reactivation in patients with CAR T-cell therapy;Blood;2020-07-23

5. Mitomycin, 5-fluorouracil, leflunomide, and mycophenolic acid directly promote hepatitis B virus replication and expression in vitro;Virology Journal;2020-07-01